Structure | Chemical Name | CAS | MF |
|
ATRIAL NATRIURETIC FACTOR (3-28) (HUMAN)
|
102686-43-1
|
C118H187N43O36S3
|
|
trans-1-Chloro-3,3,3-trifluoroprop-1-ene
|
102687-65-0
|
C3H2ClF3
|
|
3H-Pyrazol-3-one, 2,4-dihydro-5-phenyl-2-(1,2,5-trimethyl-4-piperidiny l)-
|
102689-19-0
|
C17H23N3O
|
|
4-benzyl-5-phenyl-2-(1,2,5-trimethyl-4-piperidyl)-4H-pyrazol-3-one
|
102689-20-3
|
C24H29N3O
|
|
BIS(2-CYANOETHYL)-N,N-DIISOPROPYL PHOSPHORAMIDITE
|
102690-88-0
|
C12H22N3O2P
|
|
2-Cyanoethyl N,N,N',N'-tetraisopropylphosphorodiamidite
|
102691-36-1
|
C15H32N3OP
|
|
(2R,3S,5R)-2-((BIS(4-METHOXYPHENYL)(PHENYL)METHOXY)METHYL)-5-(2-ISOBUTYRAMIDO-6-(4-NITROPHENETHOXY)-9H-PURIN-9-YL)TETRAHYDROFURAN-3-YL 2-CYANOETHYL DIISOPROPYLPHOSPHORAMIDITE
|
102691-37-2
|
C52H61N8O10P
|
|
(S)-(+)-2-METHOXY-2-(1-NAPHTHYL)PROPIONIC ACID
|
102691-93-0
|
C14H14O3
|
|
4-Isoxazolecarboximidamide,N-hydroxy-3,5-dimethyl-
|
102692-02-4
|
C6H9N3O2
|
|
4,4'-DICHLOROCHALCONE
|
102692-35-3
|
C15H10F2O
|
|
2(1H)-Pyrazinone,5-hydroxy-3-methyl-(9CI)
|
102694-22-4
|
C5H6N2O2
|
|
stemphyltoxin III
|
102694-32-6
|
C20H12O6
|
|
SODIUMPENTACHLOROSTANNITE
|
102696-35-5
|
Cl.Cl4Sn.Na
|
|
3-(3-THIENYL)ACRYLIC ACID
|
102696-71-9
|
C7H6O2S
|
|
ETHYL 4-CARBOETHOXYBENZOYLFORMATE
|
102697-43-8
|
C13H14O5
|
|
1-methyl-4-piperidyl 4'-fluorobenzoate
|
102698-53-3
|
C13H16FNO2
|
|
3-diethylamino-1-propanol 2-phenylbenzoate
|
102698-88-4
|
|
|
P-HEXADECYLOXYNITROBENZENE
|
102703-33-3
|
C22H37NO3
|
|
5-(3,4,5-Trimethoxy-phenyl)-3,4-dihydro-2H-pyrrole
|
102705-35-1
|
C16H15N
|
|
METHYL 7-METHOXY-2,2-DIPHENYL-1,3-BENZODIOXOLE-5-CARBOXYLATE
|
102706-14-9
|
C22H18O5
|
|
Cyanamide, (3-acetylphenyl)- (9CI)
|
102711-76-2
|
C9H8N2O
|
|
5(4H)-Oxazolone,4-(1-methyl-2-pyrrolidinylidene)-(9CI)
|
102713-14-4
|
C8H10N2O2
|
|
klebocin
|
102714-08-9
|
|
|
(2E)-2-ethylidenebutanedioic acid
|
102714-66-9
|
C6H8O4
|
|
(E)-1-[4-(4-amino-6,7-dimethoxy-quinazolin-2-yl)piperazin-1-yl]-3-(4-a zidophenyl)prop-2-en-1-one
|
102714-70-5
|
C23H24N8O3
|
|
4,5-DIMETHOXY-2-NITROBENZONITRILE
|
102714-71-6
|
C9H8N2O4
|
|
t-butyloxycarbonyl-methionyl-aminobutyryl-phenylalanine methyl ester
|
102714-80-7
|
C24H37N3O6S
|
|
1,1′-Biphenyl, 2-fluoro-4,4′-bis(trans-4-propylcyclohexyl)-
|
102714-93-2
|
C30H41F
|
|
TRANS,TRANS-4''-PENTYL-4-METHOXY-BICYCLOHEXYL
|
102714-95-4
|
C18H34O
|
|
TRANS,TRANS-4''-PENTYL-4-ETHOXY-BICYCLOHEXYL
|
102714-96-5
|
C19H36O
|
|
4-Nitrophenyl4,6-cyclohexylidene-b-D-mannopyranoside
|
102717-16-8
|
C18H23NO8
|
|
p-Nitrophenyl 3-O-Benzoyl-4,6-cyclohexylidene--D-mannopyranoside
|
102717-17-9
|
C25H27NO9
|
|
4-trifluoroacetamidophenylmannopyranosyl-(1-3)-O-(mannopyranosyl-(1-6))-mannopyranoside
|
102717-28-2
|
C26H36F3NO17
|
|
(R)-5-(TERT-BUTYLDIPHENYLSILOXYMETHYL)DIHYDRO-2(3H)FURANONE
|
102717-29-3
|
C21H26O3Si
|
|
propyl O-(3,6-di-O-methyl-beta-glucopyranosyl)-(1-4)-O-(2,3-di-O-methyl-alpha-rhamnopyranosyl)-(1-2)-3-O-methyl-alpha-rhamnopyranoside
|
102717-63-5
|
C26H48O14
|
|
.beta.-D-erythro-Hexopyranos-2-ulose, 1,6-anhydro-3-deoxy-4-O-(phenylmethyl)-
|
102719-10-8
|
C13H14O4
|
|
.beta.-D-arabino-Hexopyranose, 1,6-anhydro-3-deoxy-4-O-(phenylmethyl)-
|
102719-11-9
|
C13H16O4
|
|
.beta.-D-arabino-Hexopyranose, 1,6-anhydro-3-deoxy-4-O-(phenylmethyl)-, acetate
|
102719-12-0
|
C15H18O5
|
|
.beta.-D-ribo-Hexopyranose, 1,6-anhydro-3-deoxy-4-O-(phenylmethyl)-, acetate
|
102719-13-1
|
C15H18O5
|
|
.beta.-D-arabino-Hexopyranose, 1,6-anhydro-3-deoxy-, 2-acetate
|
102719-14-2
|
C8H12O5
|
|
.beta.-D-ribo-Hexopyranose, 1,6-anhydro-3-deoxy-, 2-acetate
|
102719-15-3
|
C8H12O5
|
|
.beta.-D-threo-Hexopyranos-4-ulose, 1,6-anhydro-3-deoxy-, acetate
|
102719-16-4
|
C8H10O5
|
|
.beta.-D-erythro-Hexopyranos-4-ulose, 1,6-anhydro-3-deoxy-, acetate
|
102719-17-5
|
C8H10O5
|
|
1,4:6,10-Diepoxy-1H-cycloheptcoxepin-5,9-dione, 3,4,5a,6,10,10a-hexahydro-, 1R-(1.alpha.,4.alpha.,5a.beta.,6.alpha.,10.alpha.,10a.beta.)-
|
102719-18-6
|
C11H10O5
|
|
3-oxo-11-methoxytabersonine
|
102719-84-6
|
C22H24N2O4
|
|
crebanine N-oxide
|
102719-85-7
|
C20H21NO5
|
|
1-(4-coumaroyl)alpha-rhamnopyranose
|
102719-86-8
|
|
|
(-)-3-Methyl-N-[5a,6,7,8-tetrahydro-4-methyl-1,5-dioxo-5H-pyrrolo[1,2-c][1,3]oxazepin-3-yl]butanamide
|
102719-89-1
|
|
|
(-)-N-(5a,6,7,8-Tetrahydro-4-methyl-1,5-dioxo-5H-pyrrolo[1,2-c][1,3]oxazepin-3-yl)hexanamide
|
102719-90-4
|
C15H22N2O4
|
|
Benzenemethanol, alpha-(((1,1-dimethylethyl)amino)methyl)-2-hydroxy-, (+-)-
|
102722-02-1
|
|
|
N-(pivaloyloxy)phenacetin
|
102725-57-5
|
C15H21NO4
|
|
self-incompatibility glycoprotein, Nicotiana
|
102726-76-1
|
|
|
hyacinthoside
|
102728-60-9
|
C51H83NO20
|
|
9-(2'-ACETOXYETHOXYMETHYL)-GUANINE
|
102728-64-3
|
C10H13N5O4
|
|
1H-1,2,4-Triazol-3-amine,5-(methylsulfinyl)-(9CI)
|
102728-85-8
|
C3H6N4OS
|
|
7-DEAZAGUANOSINE
|
102731-45-3
|
C11H14N4O5
|
|
5'-deoxy-5'-iodo-9-deazainosine
|
102731-46-4
|
C11H12IN3O4
|
|
dioctanoylphosphatidic acid
|
102731-57-7
|
C19H37O8P
|
|
rhizolotine
|
102731-62-4
|
C11H18N2O7
|
|
2-(1H-pyrazol-5-yl)acetic acid
|
102732-63-8
|
C5H6N2O2
|
|
Sometripor
|
102733-72-2
|
|
|
A-CHLORO-DELTA-GUANIDINO-N-VALERIC ACID HCL CRYSTAL
|
102733-82-4
|
C6H13Cl2N3O2
|
|
Punctaporonin D
|
102734-12-3
|
C15H24O3
|
|
2-Pyrrolidinecarboxamide,5-ethyl-,(2S-trans)-(9CI)
|
102734-97-4
|
C7H14N2O
|
|
3-O-demethylsporaricin A
|
102735-33-1
|
C16H34ClN5O5
|
|
L-CYCLOPROPYLALANINE
|
102735-53-5
|
C6H11NO2
|
|
5-CHLORO INDAZOLE-3-CARBOXALDEHYDE
|
102735-84-2
|
C8H5ClN2O
|
|
4-CHLORO-3-(1H)INDAZOLE CARBOXALDEHYDE
|
102735-85-3
|
C8H5ClN2O
|
|
4-FLUORO-2,6-DINITROTOLUENE
|
102735-88-6
|
C7H5FN2O4
|
|
2-CHLORO-4-METHOXY-6-NITRO TOLUENE
|
102735-89-7
|
C8H8ClNO3
|
|
(5-Chloro-1H-indazol-3-yl)-methanol ,97%
|
102735-90-0
|
C8H7ClN2O
|
|
6-Ethyl-3-octanone, 5-(t-butyldimethylsilyloxy)-7-triethylsilyloxy-
|
102736-52-7
|
C22H48O3Si2
|
|
1-(N-(2-hydroxyethyl)acetamido)-2-hydroxylaminoimidazole
|
102737-46-2
|
C7H12N4O3
|
|
2,7-Dihydroxy-3,6,10,11-tetrakis(pentyloxy)triphenylene
|
102737-76-8
|
C38H52O6
|
|
2-CHLORO-1,3-DIFLUOROPROPANE
|
102738-79-4
|
C3H5ClF2
|
|
(5-Acetyl-4-methylpyrimidin-2-yl)cyanamide
|
102739-38-8
|
C8H8N4O
|
|
Cyanamide, (4-ethyl-2-pyrimidinyl)- (9CI)
|
102739-39-9
|
C7H8N4
|
|
5-Pyrimidinecarboxylicacid,2-(cyanoamino)-4-methyl-,ethylester(9CI)
|
102739-40-2
|
C9H10N4O2
|
|
1-(4-methylpyrimidin-2-yl)thiourea
|
102739-58-2
|
C6H8N4S
|
|
1,2-Benzisoxazole-3-methanol, 6-nitro-
|
102741-52-6
|
C8H6N2O4
|
|
5-chloro-5,8-dideazaisofolic acid
|
102743-78-2
|
C21H20ClN5O6
|
|
BIOCYTIN HYDRAZIDE HYDROCHLORIDE
|
102743-85-1
|
C16H30N6O3S
|
|
Sometribove
|
102744-97-8
|
|
|
7-aminoketanserin
|
102745-99-3
|
C22H23FN4O3
|
|
H-Gln(Trt)-OH
|
102747-84-2
|
C24H24N2O3
|
|
N,5-Dibenzyl-5-hydroxy-indole-3-glyoxylaMide
|
102754-41-6
|
C24H20N2O3
|
|
4(3H)-Quinazolinone, 8-methoxy-2-(p-methoxystyryl)-3-phenyl- (6CI)
|
102754-47-2
|
C24H20N2O3
|
|
1,3-Bis(p-tert-butylphenoxy)propane
|
102756-13-8
|
C23H32O2
|
|
N-methyl-4-(8-phenoxyoctoxy)aniline
|
102759-19-3
|
C21H29NO2
|
|
Propanedioic acid, diethyl ester, reaction products with 1,6-diisocyanatohexane homopolymer, ethyl acetoacetate, 2-ethyl-1,3-hexanediol and 5-isocyanato-1-(isocyanatomethyl) -1,3,3-trimethylcyclohexane homopolymer
|
102763-23-5
|
C41H70N4O13
|
|
2-METHYL-4-(4-TRIFLUOROMETHYL-PHENOXY)-PHENYLAMINE
|
102766-74-5
|
C14H12F3NO
|
|
HC BLUE NO. 10
|
102767-27-1
|
C12H19N3O5
|
|
102767-28-2
|
102767-28-2
|
|
|
Levetiracetam
|
102767-28-2
|
C8H14N2O2
|
|
(S)-N-(1-aMino-1-oxobutan-2-yl)-4-chlorobutanaMide
|
102767-31-7
|
C8H15ClN2O2
|
|
DRIVOSOL
|
102767-64-6
|
C11H28
|
|
10-isobutyryl dithranol
|
102768-28-5
|
C18H16O4
|
|
11-deoxy-11,12-methanoprostaglandin E2
|
102769-45-9
|
C21H32O4
|
|
capuramycin
|
102770-00-3
|
C23H31N5O12
|
|
2-Iodo-5-(trifluoroMethyl)phenol
|
102771-00-6
|
C7H4F3IO
|